BRIEF published on 04/24/2025 at 19:44, 1 year ago Mauna Kea Technologies : Résultats 2024 et Perspectives Résultats 2024 Défis Financiers Cellvizio CellTolerance Mauna Kea
BRIEF published on 04/24/2025 at 19:44, 1 year ago Mauna Kea Technologies: 2024 Results and Outlook Financial Challenges Cellvizio 2024 Results CellTolerance Mauna Kea
PRESS RELEASE published on 04/24/2025 at 19:39, 1 year ago Informations privilégiées / Communiqué sur comptes, résultats Mauna Kea Technologies annonce ses résultats financiers pour l'année 2024 et fait le point sur son activité. Progression malgré des défis avec lancement de CellTolerance et négociations en cours Résultats Financiers Croissance Négociations Mauna Kea Technologies CellTolerance
PRESS RELEASE published on 04/24/2025 at 19:39, 1 year ago Inside Information / News release on accounts, results Mauna Kea Technologies reports full year 2024 financial results and business update, discusses challenges and operational progress amidst external headwinds, strategic partnerships, and financial outlook Financial Results Strategic Partnerships Business Update Financial Outlook Mauna Kea Technologies
BRIEF published on 04/01/2025 at 09:34, 1 year 1 month ago Mauna Kea Technologies Enters Licensing Talks for Cellvizio® Licensing Agreement Financial Strategy Mauna Kea Technologies Cellvizio® Platform Therapeutic Interest
BRIEF published on 04/01/2025 at 09:34, 1 year 1 month ago Mauna Kea Technologies entame des négociations pour l'octroi d'une licence pour Cellvizio® Stratégie Financière Mauna Kea Technologies Contrat De Licence Plateforme Cellvizio® Intérêt Thérapeutique
PRESS RELEASE published on 04/01/2025 at 09:29, 1 year 1 month ago Inside Information / Other news releases Mauna Kea Technologies enters exclusive negotiations for Cellvizio® licensing agreement in important therapeutic area with major player, intensifies financing discussions with investors Investors Licensing Agreement Mauna Kea Technologies Cellvizio Therapeutic Area
PRESS RELEASE published on 04/01/2025 at 09:29, 1 year 1 month ago Informations privilégiées / Autres communiqués Mauna Kea Technologies entre en négociation exclusive pour licence Cellvizio dans large domaine thérapeutique avec acteur majeur du secteur. Discussions de licence et financement en cours Financement Négociation Exclusive Mauna Kea Technologies Cellvizio Domaine Thérapeutique
BRIEF published on 03/03/2025 at 18:00, 1 year 2 months ago ESGE Endorses Mauna Kea's Cellvizio® for Enhanced Pancreatic Cyst Diagnosis Cellvizio® Pancreatic Cysts NCLE Technology ESGE Endorsement Diagnostic Accuracy
BRIEF published on 03/03/2025 at 18:00, 1 year 2 months ago L'ESGE recommande le Cellvizio® de Mauna Kea pour un meilleur diagnostic des kystes pancréatiques Cellvizio® Kystes Pancréatiques Technologie NCLE Approbation De L'ESGE Précision Du Diagnostic
Published on 05/06/2026 at 15:25, 34 minutes ago Electrovaya Announces Date for Q2-2026 Financial Results & Conference Call
Published on 05/06/2026 at 15:15, 44 minutes ago Karbon-X Reports Increased Engagement as Canadian Facilities Reassess Compliance Exposure Ahead of Carbon Deadlines
Published on 05/06/2026 at 15:12, 47 minutes ago Revival Gold Announces Closing of $33 Million Brokered Private Placement
Published on 05/06/2026 at 15:00, 59 minutes ago Infield Minerals Announces Option Agreement for the Detroit Gold Property in Utah
Published on 05/06/2026 at 15:00, 59 minutes ago Vox Royalty Announces Virtual Investor Day and Q1 2026 Earnings Release Date
Published on 05/06/2026 at 15:41, 17 minutes ago The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 05/06/2026 at 15:35, 23 minutes ago MUSIC ICONS: Julien's Presents a Landmark Rock and Roll Memorabilia Auction
Published on 05/06/2026 at 15:34, 24 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 05/06/2026 at 14:59, 59 minutes ago NRJ Group - Information relative aux droits de vote au 30.04.2026 (French & English)
Published on 05/06/2026 at 11:36, 4 hours 22 minutes ago Nombre total de droits de vote et d'actions composant le capital social
Published on 05/06/2026 at 10:09, 5 hours 50 minutes ago Guillemot Corporation : Information regarding the total number of voting rights and shares 30/04/2026
Published on 05/06/2026 at 10:09, 5 hours 50 minutes ago Guillemot Corporation : Informations relatives au nombre total de droits de vote et d’actions 30/04/2026
Published on 05/06/2026 at 09:09, 6 hours 50 minutes ago Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
